The pursuit for biotherapeutic proteins in basic research, clinical diagnostics and therapy continues at an exponential pace. Consequently, the demands for efficient expression and production of these valuable biomolecules face challenges to improve quantity and quality while minimising time and cost. Thus, an increasing variety of recombinant production platforms, called “cell factories,” are being developed. Unfortunately, there is no universal production system which can guarantee high yields, since each protein can vary in terms of expression and production.

We invite presentation proposals on the following preliminary topics with an emphasis on the biotherapeutic protein product -- including recombinant proteins, antibodies, membrane proteins, and difficult-to-express proteins.

Coverage will include, but is not limited to:

  • Cell Factories
    • Mammalian (CHO, HEK293, NS0)
    • Insect (Baculovirus, Drosophila)
    • Bacterial (Escherichia coli)
    • Yeast (Pichia pastoris, Saccharomyces cerevisiae)
    • Other (Algae, Tobacco)
  • Host Selection
  • Cloning Strategies
  • Biotherapeutic Proteins
    • Recombinant Proteins
    • Antibodies
    • Membrane Proteins
    • Difficult-to-Express Proteins
  • Matching Host to Protein of Choice
  • Re]Engineering Existing Systems for Better Performance
  • Automation for Higher Throughput
  • Faster Turnaround Times
  • Development of Analytical Assays to Determine Identity, Purity and Biological Activity
  • Increasing Speed and Lowering Cost
  • Stable Expression vs. Transient Expression
  • Case Studies

* The program is subject to change without notice, due to unforeseen reason.